ENDLOS-TURBO PUT - AMGEN | Real-time Boerse Frankfurt Warrants 03:35:10 2024-05-29 am EDT | ||
| 9.58 EUR | 0.00% |
|
| Current month | -21.60% | ||
| 1 month | -23.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 9.58 | 0.00% |
| 24-05-28 | 9.58 | +9.61% |
| 24-05-27 | 8.74 | -2.78% |
| 24-05-24 | 8.99 | +0.56% |
| 24-05-23 | 8.94 | +5.55% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 03:35 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ85UC |
| ISIN | DE000DJ85UC5 |
| Date issued | 2024-02-05 |
| Strike | 402.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.455 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.49 € |
|---|---|
| Lowest since issue | 7.28 € |
| Spread | 0.24 € |
| Spread % | 2.43% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
